Nanoparticles as controlled release drug delivery systems – A case study in SciFinder-n

Rapid growth in nanotechnology is increasing the likelihood of engineered nanomaterials coming into contact with humans and the environment. This field of nanoparticle research has drawn much attention in the past decade as a result of the search for new materials.

Drug delivery systems-based nanoparticles can be designed to improve the pharmacological and therapeutic properties of drugs administered parenterally, for example. Another specific example is in the field of cancer therapeutics. Early clinical results suggest that nanoparticle therapeutics for cancer can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumors and active cellular uptake¹.

SciFinder-n allows a precise research starting by a specific drug or an imagine substance or by analyzing a general (or much more specific) concept. With SciFinder-n you can be sure you are in line with literature as well as with patents in your field of research. This is the biggest and most comprehensive scientific/ life sciences database in the world.

Join us to hear about nanoparticles as drug delivery systems, using SciFinder-n.

1.Davis M.E. et al, Nature reviews. Drug discovery (2008), 7(9), 771.